FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

15989011000001102: Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56602301000001117 Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56602401000001113 Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Is a Ciprofloxacin 250mg tablets 10 tablet true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Has AMP Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Has specific active ingredient Ciprofloxacin hydrochloride true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ciprofloxacin true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ciprofloxacin 250mg tablets (Bristol Laboratories Ltd) 10 tablet Has basis of strength substance Ciprofloxacin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start